BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Job Trends

  Vizient Drug Price Forecast Projects 4.57 Percent Increase in Hospital Drug Spending for 2020

  Vizient, Inc. has released its July 2019 Drug Price Forecast projecting health systems, including inpatient and non-acute environments, can expect a 4.57 percent increase for pharmaceutical purchases made from Jan. 1, 2020 to Dec. 31, 2020.

  August 6, 2019

   · 

  6 min read
• Business

  Bio-Techne Releases Fourth Quarter Fiscal 2019 Results

  Bio-Techne Corporation reported its financial results for the fourth quarter ended June 30, 2019.

  August 6, 2019

   · 

  17 min read
• Deals

  Bio-Techne Declares Dividend payable August 30, 2019

  Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended June 30, 2019.

  August 6, 2019

   · 

  1 min read
• Business

  Regeneron Reports Second Quarter 2019 Financial and Operating Results

  Regeneron Pharmaceuticals, Inc. announced financial results for the second quarter of 2019 and provided a business update.

  August 6, 2019

   · 

  17 min read
• Genetown

  Epizyme to Present at the Wedbush PacGrow 2019 Healthcare Conference

  Epizyme, Inc. announced that Robert Bazemore, president and chief executive officer, will present at the Wedbush PacGrow 2019 Healthcare Conference on Tuesday, Aug. 13, 2019 at 10:55 a.m. ET in New York City.

  August 6, 2019

   · 

  1 min read
• Business

  Sage Therapeutics Announces Second Quarter 2019 Financial Results and Highlights Pipeline and Business Progress

  Sage Therapeutics, a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, reported business highlights and financial results for the second quarter ended June 30, 2019.

  August 6, 2019

   · 

  21 min read
• Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market 2019-2023 | Key Insights and Forecasts | Technavio

  The global pharmaceutical contract research and manufacturing market is expected to grow by USD 62.67 billion during the period 2019-2023, according to the latest market research report by Technavio.

  August 6, 2019

   · 

  4 min read
• Deals

  Milestone Pharmaceuticals to Host Mid-Year Update Conference Call

  Milestone Pharmaceuticals Inc. announced that it will host a mid-year update conference call on Tuesday, August 13, 2019 at 8:00 a.m. Eastern Time.

  August 6, 2019

   · 

  1 min read
• Business

  Avanos Medical, Inc. Announces Second Quarter 2019 Results, Completes Acquisition of NeoMed, Inc., Announces Agreement to Acquire Substantially All the Assets of Summit Medical Products, Inc., Announces Partnership Agreement with BioQ Pharma

  Avanos Medical, Inc. reported second quarter 2019 results and revised its full-year 2019 outlook.

  August 6, 2019

   · 

  10 min read
• Business

  CeloNova Announces Appointment of New President and CEO

  Company positions itself for expected near-term commercial growth within coronary stent market treating high bleeding risk patients undergoing PCI

  August 6, 2019

   · 

  4 min read